Based in Switzerland for over twenty years, Apogex helps global pharma partners improve healthcare and save lives worldwide by giving patients in new markets access to the latest therapies, backed by the reassurance of Swissmedic approval.
Working with our global pharma partners and our local network of in-market healthcare distributors, our experienced team helps to integrate legal requirements, local regulatory approvals and supply chain operations to ensure the smooth introduction of a therapy into a new market area. We can also work as distributor ourselves when our partners require it, in accordance with local regulation.
Apogex is a company that offers many solutions tailored to help multinational pharmaceutical companies bringing their innovative drugs to the emerging markets.
We obtain approval and licencing for all the therapies we trade and distribute from Swissmedic, the authority responsible for the authorisation and supervision of therapeutic products in Switzerland